ILMN
Illumina, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$217.37
−1.94%Forward multiples
Based on analyst estimates
- P/E forward
- 38.10x
- P/E 2026E
- 40.52x
- P/E 2027E
- 35.69x
- P/E 2028E
- 30.86x
- P/S forward
- 6.92x
Trailing multiples
Trailing twelve months
- P/E TTM
- 40.18x
- PEG TTM
- 7.33x
- Price / book
- 11.57x
- Price / sales
- 7.31x
- Price / cash flow
- 29.98x
Enterprise value
- Enterprise value
- $34.2B
- EV / sales
- 7.61x
- EV / EBITDA
- 25.08x
- EV / EBIT
- 36.29x
- Market cap
- $32.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026